Screener
BioMarin Pharmaceuticals BMRN Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $874.01M-28.0% | $3.07B+193% | $1.31B+39.1% | $1.25B+85.1% | $1.21B+24.9% | ||
| $0-100% | $0-100% | $248.93M+27.7% | $227.73M-10.7% | $218.31M-13.4% | ||
| $1.06B+24.0% | $903.91M+22.3% | $908.21M+37.5% | $790.27M+1.6% | $855.86M+23.8% | ||
| $1.78B+33.0% | $1.27B-0.1% | $1.3B+5.4% | $1.38B+17.2% | $1.34B+13.2% | ||
| $3.97B+4.4% | $4.61B+32.8% | $3.95B+22.3% | $3.85B+26.1% | $3.81B+16.7% | ||
| $989.99M-3.9% | $958.07M-7.2% | $952.51M-8.7% | $1.04B-0.7% | $1.03B-2.1% | ||
| $655.75M+234% | $196.2M0.0% | $196.2M0.0% | $196.2M0.0% | $196.2M0.0% | ||
| $4.88B+1,936% | $204.66M-17.3% | $213.84M-16.2% | $233.11M-10.7% | $239.62M-9.8% | ||
| $11.72B+57.2% | $8.59B+20.2% | $7.59B+8.7% | $7.61B+11.1% | $7.46B+5.5% | ||
| $1.01B+47.0% | $793.15M+26.3% | $759.03M+25.0% | $798.44M+11.6% | $684.25M+19.5% | ||
| $658.2M— | —— | $0— | —— | —— | ||
| $1.66B+143% | $793.15M+26.3% | $759.03M+25.0% | $798.44M+11.6% | $684.25M-35.9% | ||
| $3.53B+488% | $1.43B+138% | $597.18M— | $600M0.0% | $600M-45.5% | ||
| $5.4B+278% | $2.38B+75.8% | $1.51B+13.2% | $1.56B+8.4% | $1.43B-19.7% | ||
| 500M0.0% | 500M0.0% | 500M+261,680% | 500M0.0% | 500M0.0% | ||
| $304.5M+31.5% | $259.73M+2,983% | $154.21M+179% | $200.78M+163% | $231.52M+154% | ||
| $6.32B+4.9% | $6.21B+7.2% | $6.09B+7.6% | $6.06B+11.9% | $6.03B+14.0% | ||
| $11.72B+57.2% | $8.59B+20.2% | $7.59B+8.7% | $7.61B+11.1% | $7.46B+5.5% |
FAQ
- What are BioMarin Pharmaceuticals's total assets?
- BioMarin Pharmaceuticals (BMRN) holds $11.7B in total assets, up 57.2% year over year.
- How much debt does BioMarin Pharmaceuticals have?
- BioMarin Pharmaceuticals carries $4.2B in total debt against $6.3B of shareholders' equity, a debt-to-equity ratio of 0.66.
- How much cash does BioMarin Pharmaceuticals have?
- BioMarin Pharmaceuticals holds $874.0M in cash and equivalents.
- Can BioMarin Pharmaceuticals cover its short-term obligations?
- Its current ratio is 2.39 — current assets exceed current liabilities.
- Where does BioMarin Pharmaceuticals's balance sheet data come from?
- Every line is extracted from BioMarin Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
